the primary analysis of efficacy was based on the incidence of the first event of stroke , myocardial infarction or cardiovascular death , but excluding events that occurred more than 28 days after complete withdrawal from study medication for whatever reason .
C0027051
myocardial infarction
C0007226
cardiovascular